Ropivacaine

Generic Name: Ropivacaine

Brand Names: Naropin

Drug Type: Small Molecule

Chemical Formula: C_₁₇H_₂₆N_₂O

CAS Number: 84057-95-4

Unique Ingredient Identifier: 7IO5LYA57N

Background: Ropivacaine is an aminoamide local anesthetic drug marketed by AstraZeneca under the trade name Naropin. It exists as a racemate of its S- and R-enantiomers, although the marketed form is supplied only as the purified S-enantiomer.

Indication: Ropivacaine is indicated in adult patients for the induction of regional or local anesthesia for surgery or acute pain management.

Associated Conditions: Acute Pain, Postoperative pain

Associated Therapies: Surgical anesthesia therapy

Clinical Trials

The Effect of Tramadol on Interscalene Brachial Plexus Block

Phase 2

Completed

Conditions: Shoulder Fracture
Shoulder Dislocation
Rotator Cuff Injury
Shoulder Arthritis

Interventions: Drug: Ropivacaine - Tramadol
Drug: Ropivacaine

First Posted Date: 2014-07-08

Last Posted Date: 2016-01-05

Lead Sponsor: Asklepieion Voulas General Hospital

Target Recruit Count: 80

Registration Number: NCT02182752

Locations: 🇬🇷
Asklepieion Hospital of Voula, Athens, Attica, Greece

Pulmonary Function and Interscalene Block

Not Applicable

Completed

Conditions: Shoulder Arthroscopy

Interventions: Drug: ropivacaine

First Posted Date: 2014-07-03

Last Posted Date: 2019-02-20

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 50

Registration Number: NCT02181296

Prolongation of Pain Free Time by the Use of Dexamethasone in Peripheral Nerve Blockade

Phase 4

Conditions: Interscalene Block
Shoulder Arthroscopy
Dexamethasone
Low Volume Regional Anesthesia

Interventions: Drug: Dexamethasone acetate
Drug: Placebo
Drug: Ropivacaine

First Posted Date: 2014-06-30

Last Posted Date: 2014-06-30

Lead Sponsor: Landesklinikum Sankt Polten

Target Recruit Count: 109

Registration Number: NCT02178449

Locations: 🇦🇹
Landesklinikum Sankt Pölten, Sankt Pölten, Lower Austria, Austria

Intraoperative Local Anaesthetic and Postoperative Pain

Not Applicable

Completed

Conditions: Postoperative Pain

Interventions: Procedure: Wound infiltration with local anaesthetic
Drug: Ropivacaine

First Posted Date: 2014-06-24

Last Posted Date: 2014-06-24

Lead Sponsor: Hellenic Red Cross Hospital

Target Recruit Count: 400

Registration Number: NCT02171299

Locations: 🇬🇷
"Korgialenio-Benakio", Hellenic Red Cross Athens General Hospital, Greece, Athens, Greece

Pre-op Paravertebral Blocks to Decrease Post-op Pain Following Mastectomy With Immediate Tissue Expander (TE) Reconstruction

Phase 3

Terminated

Conditions: Postoperative Pain
Postoperative Nausea and Vomiting
Quality of Life

Interventions: Drug: Saline
Drug: Ropivacaine

First Posted Date: 2014-06-12

Last Posted Date: 2020-04-16

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 18

Registration Number: NCT02161705

Locations: 🇺🇸
Johns Hopkins University School of Medicine, Baltimore, Maryland, United States

The Use of Intraperitoneal Ropivacaine in Bariatric Bypass Surgery

Phase 3

Completed

Conditions: Bariatric Surgery Candidate

Interventions: Drug: Normal Saline
Drug: Ropivacaine

First Posted Date: 2014-06-03

Last Posted Date: 2019-03-19

Lead Sponsor: Ottawa Hospital Research Institute

Target Recruit Count: 120

Registration Number: NCT02154763

Locations: 🇨🇦
The Ottawa Hospital, Ottawa, Ontario, Canada

Analgesic Efficacy of Perineural Dexamethasone During Supraclavicular Block for Hand Surgery

Phase 2

Terminated

Conditions: Surgery, Hand

Interventions: Drug: Ropivacaine
Other: Placebo
Drug: Dexamethasone

First Posted Date: 2014-06-03

Last Posted Date: 2014-09-11

Lead Sponsor: Duke University

Target Recruit Count: 5

Registration Number: NCT02154048

A Comparison of Ropivacaine Alone Versus Combination of Dexamethasone and Clonidine for Block

Completed

Conditions: Upper Extremity Surgery

Interventions: Drug: Ropivacaine
Drug: Ropivacaine and dexamethasone
Drug: Ropivacaine and clonidine
Drug: Ropivacaine, dexamethasone and clonidine

First Posted Date: 2014-05-30

Last Posted Date: 2019-07-05

Lead Sponsor: University of Texas Southwestern Medical Center

Target Recruit Count: 97

Registration Number: NCT02151487

Locations: 🇺🇸
Parkland Health Hospital System, Dallas, Texas, United States

Prevention of Myocardial Dysfunction and Injury Resulting From Salter Innominate Osteotomy by Caudal Block

Phase 4

Conditions: Cardiac Dysfunction
Myocardial Injury

Interventions: Drug: saline
Drug: ropivacaine

First Posted Date: 2014-05-22

Last Posted Date: 2014-08-26

Lead Sponsor: Si-Qin Chen

Target Recruit Count: 40

Registration Number: NCT02144766

Locations: 🇨🇳
Xinhua Hospital, Shanghai, China

The Study of Regional Hemodynamic Changes After Specific Brachial Plexus Block by Ultrasound Guidance

Phase 1

Completed

Conditions: Upper Limb Nerve Block

Interventions: Procedure: specific nerve block
Drug: ropivacaine

First Posted Date: 2014-05-16

Last Posted Date: 2014-08-01

Lead Sponsor: Wenzhou Medical University

Target Recruit Count: 110

Registration Number: NCT02139982

Locations: 🇨🇳
The Second Affiliated Hospital & Yuying Children hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China

Drug Development Updates

Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.

Home Terms & Conditions Privacy Policy